Riskpilot← Back to searchSign inGet full accessMeribel Pharma Solna AB
ABActiveOrg 5568250095Gårdsvägen 10 AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 201073 employees
Revenue 2024
SEK 104,3M
-13% vs 2023
EBITDA margin
-15.2%
-217% vs 2023
Equity ratio
50.0%
Financial strength
Net profit 2024
SEK -6,3M
-202% vs 2023
| Revenue | SEK 104,3M | -13% |
| EBITDA | SEK -15,8M | -217% |
| Net profit | SEK -6,3M | -202% |
| Total assets | SEK 73,6M | +12% |
| Equity | SEK 36,8M | +11% |
| Employees | 73 | — |
Legal name
Meribel Pharma Solna AB
Org number
5568250095
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
12 november 2010
Share capital
SEK 50 000
Employees
73 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Leonard, Stephen Ira Tomlinson Jr, Percy Charwood Firman tecknas av Gren, Carl Olof Torkel i förening med en av Leonard, Stephen Ira Tomlinson Jr, Percy Charwood Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva utveckling, tillverkning och försäljning av läkemedel, naturläkemedel, kosttillskott, medicinska hjälpmedel och därmed förenlig verksamhet, samt utveckla och förvalta produkttillgångar och andra tillgångar inom denna bransch och närliggande branscher.
Address
Gårdsvägen 10 A
Email
ap.sweden@meribelpharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 103 826 | 100 205 | 93 458 | 120 071 | 104 325 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 031 | −2 601 | −4 546 | 13 588 | −15 846 |
| Depreciation & amort. | −4 105 | −3 868 | −3 377 | −3 213 | −3 412 |
| EBIT | 1 926 | −6 469 | −7 923 | 10 375 | −19 258 |
| Net financials | −1 409 | 38 | −136 | −620 | −341 |
| Profit before tax | −63 | −146 | −8 059 | 7 682 | −6 270 |
| Tax | −0 | −0 | 1 511 | −1 511 | −0 |
| Net profit | −63 | −146 | −6 548 | 6 171 | −6 270 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 57 878 | 63 385 | 49 019 | 65 801 | 73 595 |
| Equity | 34 108 | 33 439 | 26 891 | 33 063 | 36 793 |
| Long-term debt | 33 | 0 | 0 | 0 | 0 |
| Short-term debt | 21 939 | 29 946 | 22 128 | 32 738 | 36 802 |
| Total debt | 21 972 | 29 946 | 22 128 | 32 738 | 36 802 |
EBITDA margin
-15.2%
This company
15.8%
Market median
-196% vs market
20202024
Equity ratio
50.0%
This company
38.2%
Market median
+31% vs market
20202024
Return on equity
-17.0%
This company
18.4%
Market median
-192% vs market
20202024
Net profit margin
-6.0%
This company
8.1%
Market median
-174% vs market
20202024
Asset turnover
1.42×
This company
1.12×
Market median
+27% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CO Chief Executive Officer | Chief Executive Officer | 2022 |
AK Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
JR Chief Auditor | Chief Auditor | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Chairman | 2026 | |
| Former (13) | ||
| Board of Directors | 2024 – 2024 | |
| Chairman | 2024 – 2025 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 2024 – 2025 | |
| Chairman | 2020 – 2021 | |
| Board of Directors | 2025 – 2025 | |
| Chairman | 2022 – 2023 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2025 – 2025 | |
| Deputy Board Member | 2020 – 2024 | |
| Deputy Board Member | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 | |
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MAGICDOSE HOLDINGS UK LIMITED ABBW CDMO Bidco Sweden ABMeribel Pharma Sweden AB
Meribel Pharma Solna AB (this company)Board members of Meribel Pharma Solna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Olof Torkel Gren | Chief Executive Officer | 0 companies |
| Jennifer Rock Baley | Chief Auditor | 0 companies |
| Anna Kristina Stenberg | Chief Auditor | 0 companies |
| Bruce Jean-Marc Vielle | Board of Directors | 0 companies |
| Lars Jörgen Rahm | Board of Directors | 0 companies |
| Jeremy Michael Kogler | Chairman | 0 companies |
| Johanna Mirjam Kvist | Board of Directors | 0 companies |
| Nese Akay Kemahli | Board of Directors | 0 companies |
| Antoine Gilbert Delcour | Board of Directors | 0 companies |
| Per Eric Gustafsson | Board of Directors | 0 companies |
| Stephen Ira Leonard | Board of Directors | 0 companies |
| Shashank Kanubhai Patel | Board of Directors | 0 companies |
| Thomas Bengt Eldered | Chairman | 0 companies |
| Percy Charwood Tomlinson Jr | Chairman | 0 companies |
| Niklas Carl Ingvar Jaensson | Board of Directors | 0 companies |
| Eva Helene Fehrm | Chairman | 0 companies |
| Bernard Michel Noel Pluta | Board of Directors | 0 companies |
| Vladimir Alekseyevich Kasparov | Board of Directors | 0 companies |
| Valur Sveinbjörnsson | Deputy Board Member | 0 companies |
| Åsa Sofia Charlotta Bergström | Deputy Board Member | 0 companies |